I agree that this site is using cookies. You can find further informations here.
X
Rekić, Dinko
35  results:
Search for persons X
?
1

The myeloperoxidase inhibitor mitiperstat (AZD4831) does no..:

Parkinson, Joanna ; Sundell, Jesper ; Rekić, Dinko...
Pharmacology Research & Perspectives.  12 (2024)  2 - p. , 2024
Link: https://doi.org/10.1002/..
 
?
2

Population pharmacokinetics of a novel PCSK9 antisense olig..:

Clewe, Oskar ; Rekić, Dinko ; Quartino, Angelica L....
British Journal of Clinical Pharmacology.  90 (2024)  6 - p. 1503-1513 , 2024
Link: https://doi.org/10.1111/..
 
?
3

Adavosertib (AZD1775) does not prolong the QTc interval in ..:

Någård, Mats ; Ah-See, Mei-Lin ; Strauss, James...
Cancer Chemotherapy and Pharmacology.  92 (2023)  2 - p. 141-150 , 2023
Link: https://doi.org/10.1007/..
 
?
4

Verinurad does not prolong QTc interval: a thorough QT stud..:

Parkinson, Joanna ; Dota, Corina ; Källgren, Christian...
British Journal of Clinical Pharmacology.  89 (2023)  6 - p. 1747-1755 , 2023
Link: https://doi.org/10.1111/..
 
?
5

A case‐study of model‐informed drug development of a novel ..:

Knöchel, Jane ; Nilsson, Catarina ; Carlsson, Björn...
CPT: Pharmacometrics & Systems Pharmacology.  11 (2022)  12 - p. 1569-1577 , 2022
Link: https://doi.org/10.1002/..
 
?
6

Dapagliflozin Pharmacokinetics Is Similar in Adults With Ty..:

Melin, Johanna ; Tang, Weifeng ; Rekić, Dinko...
The Journal of Clinical Pharmacology.  62 (2022)  10 - p. 1227-1235 , 2022
Link: https://doi.org/10.1002/..
 
?
7

Bilirubin levels and kidney function decline: An analysis o..:

Aoki, Yasunori ; Cabrera, Claudia S. ; Ouwens, Mario...
PLOS ONE.  17 (2022)  6 - p. e0269970 , 2022
Link: https://doi.org/10.1371/..
 
?
8

AZD8233 antisense oligonucleotide targeting PCSK9 does not ..:

Rekić, Dinko ; Azarov, Ivan ; Knöchel, Jane...
British Journal of Clinical Pharmacology.  88 (2022)  11 - p. 4839-4844 , 2022
Link: https://doi.org/10.1111/..
 
?
9

Concentration‐QT modelling in early clinical oncology setti..:

Cantet, Gael ; Berges, Alienor ; O'Sullivan, Rhianna...
British Journal of Clinical Pharmacology.  88 (2021)  3 - p. 1010-1019 , 2021
Link: https://doi.org/10.1111/..
 
?
10

Pharmacokinetics of Roxadustat: A Population Analysis of 28..:

Rekić, Dinko ; Kerbusch-Herben, Virginie ; Någård, Mats...
Clinical Pharmacokinetics.  60 (2021)  6 - p. 759-773 , 2021
Link: https://doi.org/10.1007/..
 
?
11

A semi-mechanistic exposure–response model to assess the ef..:

Leander, Jacob ; Sunnåker, Mikael ; Rekić, Dinko...
Journal of Pharmacokinetics and Pharmacodynamics.  48 (2021)  4 - p. 525-541 , 2021
Link: https://doi.org/10.1007/..
 
?
12

Concentration‐QT modelling shows no evidence of clinically ..:

Voronova, Veronika ; Cullberg, Marie ; Delff, Philip...
British Journal of Clinical Pharmacology.  88 (2021)  2 - p. 858-864 , 2021
Link: https://doi.org/10.1111/..
 
?
13

QT Prolongation Risk Assessment in Oncology: Lessons Learne..:

Cohen‐Rabbie, Sarit ; Berges, Alienor C. ; Rekić, Dinko...
The Journal of Clinical Pharmacology.  61 (2021)  8 - p. 1106-1117 , 2021
Link: https://doi.org/10.1002/..
 
?
14

Higher Febuxostat Exposure Observed in Asian Compared with ..:

Rekić, Dinko ; Johansson, Susanne ; Leander, Jacob
Clinical Pharmacokinetics.  60 (2020)  3 - p. 319-328 , 2020
Link: https://doi.org/10.1007/..
 
?
15

A disease progression model of longitudinal lung function d..:

Bi, Youwei ; Rekić, Dinko ; Paterniti, Miya O....
Journal of Pharmacokinetics and Pharmacodynamics.  48 (2020)  1 - p. 55-67 , 2020
Link: https://doi.org/10.1007/..
 
1-15